Effects of benzodiazepines administration on identification of facial expressions of emotion: a meta-analysis Helena GarcezCarina FernandesAna R. Gonçalves Review 18 November 2019 Pages: 1 - 9
Varenicline for cognitive impairment in people with schizophrenia: systematic review and meta-analysis Timothy TanzerShelukumar ShahCatarina Drumonde Melo Review 03 December 2019 Pages: 11 - 19
Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics Sam G. MoretonLuke SzallaAndrew F. Arena Theoretical and Methodological Perspective 29 November 2019 Pages: 21 - 32
Pharmacological studies of effort-related decision making using mouse touchscreen procedures: effects of dopamine antagonism do not resemble reinforcer devaluation by removal of food restriction Jen-Hau YangRose E. PresbyJohn D. Salamone Original Investigation 08 August 2019 Pages: 33 - 43
Chronic ketamine abuse is associated with orexin-A reduction and ACTH elevation Ming-Chyi HuangChun-Hsin ChenKe Xu Original Investigation 03 August 2019 Pages: 45 - 53
The impact of cocaine and heroin drug history on motivation and cue sensitivity in a rat model of polydrug abuse Elizabeth A. CrummyElizabeth A. DonckelsSusan M. Ferguson Original Investigation 28 August 2019 Pages: 55 - 68
Effects of the monoamine stabilizer (-)OSU6162 on cognitive function in alcohol dependence Lotfi KhemiriPia SteenslandNitya Jayaram-Lindström Original Investigation Open access 18 October 2019 Pages: 69 - 82
MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of TrkB signaling Atsuhiro FujitaYuko FujitaKenji Hashimoto Original Investigation 15 August 2019 Pages: 83 - 92
Classical conditioning of antidepressant placebo effects in mice Samuel R. KrimmelPanos ZanosTodd D. Gould Original Investigation 17 August 2019 Pages: 93 - 102
Daily memantine treatment blunts hedonic response to sucrose in rats Adriana GalistuPaolo S. D’Aquila Original Investigation 14 August 2019 Pages: 103 - 114
The cognitive cost of reducing relapse to cocaine-seeking with mGlu5 allosteric modulators Christina GobinMarek Schwendt Original Investigation 24 August 2019 Pages: 115 - 125
Upregulation of antioxidant thioredoxin by antidepressants fluoxetine and venlafaxine Veni BhartiHua TanJun-Feng Wang Original Investigation 31 August 2019 Pages: 127 - 136
Rescuing the attentional performance of rats with cholinergic losses by the M1 positive allosteric modulator TAK-071 Aaron KucinskiKyra B. PhillipsMartin Sarter Original Investigation 16 October 2019 Pages: 137 - 153
Reciprocal cross-sensitization of D1 and D3 receptors following pharmacological stimulation in the hemiparkinsonian rat Kathryn LanzaKatherine ChemakinChristopher Bishop Original Investigation 21 August 2019 Pages: 155 - 165
Switching strategies for antipsychotic monotherapy in schizophrenia: a multi-center cohort study of aripiprazole Yoshiaki ObayashiSatoshi MitsuiNorihito Yamada Original Investigation 18 October 2019 Pages: 167 - 175
Cortisol stress response predicts 9-year risky driving convictions in male first-time driving-while-impaired offenders Thomas G. BrownMarie Claude OuimetNathaniel Moxley-Kelly Original Investigation 11 September 2019 Pages: 177 - 187
Anxiolytic effects of the novel α2δ ligand mirogabalin in a rat model of chronic constriction injury, an experimental model of neuropathic pain Hiroyasu MurasawaHiroyuki KobayashiYutaka Kitano Original Investigation 12 September 2019 Pages: 189 - 197
Improvement of autistic-like behaviors in adult rats prenatally exposed to valproic acid through early suppression of NMDA receptor function Somayeh MohammadiMajid Asadi-ShekaariMasoumeh Nozari Original Investigation 08 October 2019 Pages: 199 - 208
S-Adenosylmethionine (SAMe) monotherapy for depression: an 8-week double-blind, randomised, controlled trial Jerome SarrisJenifer MurphyGerard J. Byrne Original Investigation 11 November 2019 Pages: 209 - 218
Evidence for positive allosteric modulation of cognitive-enhancing effects of nicotine in healthy human subjects Britta HahnMegan E. ShrievesWilliam P. Fawcett Original Investigation Open access 04 November 2019 Pages: 219 - 230
Early-life blockade of NMDA receptors induces epigenetic abnormalities in the adult medial prefrontal cortex: possible involvement in memory impairment in trace fear conditioning Joachim LatuszMarzena Maćkowiak Original Investigation Open access 25 October 2019 Pages: 231 - 248
Neural correlates of reward magnitude and delay during a probabilistic delay discounting task in alcohol use disorder Laura E. DennisMilky KohnoWilliam F. Hoffman Original Investigation 31 October 2019 Pages: 263 - 278
Correction to: Neural correlates of reward magnitude and delay during a probabilistic delay discounting task in alcohol use disorder Laura E. DennisMilky KohnoWilliam F. Hoffman Correction 21 December 2019 Pages: 279 - 279
The role of methylphenidate in the treatment of catatonia Edith SciberrasJoseph Cassar Letter to the Editor 09 November 2019 Pages: 281 - 282
Specificity of a rodent alpha(α)6 nicotinic acetylcholine receptor subunit antibody Anjelica CardenasMina ElabdShahrdad Lotfipour Letter to the Editor 30 November 2019 Pages: 283 - 285
Correction to: Effects of glucagon-like peptide 1 analogs on alcohol intake in alcohol-preferring vervet monkeys Morgane ThomsenJens Juul HolstAnders Fink-Jensen Correction 25 November 2019 Pages: 287 - 287
Correction to: Co-treatment with rivastigmine and idalopirdine reduces the propensity for falls in a rat model of falls in Parkinson’s disease Ajeesh Koshy CherianAaron KucinskiMartin Sarter Correction 25 October 2019 Pages: 289 - 289
